Posts in category Healthcare


Roth Capital’s Focus Pick: Global Blood Therapeutics Inc (GBT)

Global Blood Therapeutics Inc (NASDAQ:GBT) shares rose about 9% today after the biopharmaceutical company initiated a Phase …

Read more

Valeant Pharmaceuticals Intl Inc (VRX): What This Top Analyst Is Saying

Though Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares were surging nicely ahead at almost 6% yesterday, …

Read more

Oppenheimer Stays Bullish on Sarepta Therapeutics Inc (SRPT) as the Stock Shows Signs of Weakness

Oppenheimer analyst Hartaj Singh is out with a new research note on shares of Sarepta Therapeutics Inc …

Read more

Zosano Pharma Corp (ZSAN) Shares Keep Rising on Back of Positive Momentum for M207

Zosano Pharma Corp (NASDAQ:ZSAN) shares skyrocketed over 170% in the past three days, after the company reported …

Read more

RBC Capital Sets Expectations on Valeant Pharmaceuticals Intl Inc (VRX) Ahead of Upcoming Earnings

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is scheduled to report fourth-quarter financial results before the markets open …

Read more

AEterna Zentaris Inc. (USA) (AEZS): Macrilen gets an “A” – Maxim

Maxim analyst Jason Kolbert weighed in on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $10.00 …

Read more

Gilead Sciences, Inc. (GILD): Bictegravir HIV Data Looks Good

Gilead Sciences, Inc. (NASDAQ:GILD) announced yesterday positive phase 2 results for bictegravir vs. GSK/ViiV’s dolutegravir …

Read more

Cantor Reiterates Positive Stance on Array Biopharma Inc (ARRY)

In a research report published Friday, Cantor analyst Mara Goldstein reiterated an Overweight rating on …

Read more

J.P. Morgan Comments on Immunomedics, Inc. (IMMU) and Seattle Genetics (SGEN) Deal

This morning, Immunomedics, Inc. (NASDAQ:IMMU) and Seattle Genetics, Inc. (NASDAQ:SGEN) announced a in-licensing deal, where Seattle …

Read more

This Analyst Bullish On Intercept Pharmaceuticals Inc (ICPT) Long-Term

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares rose as much as 9% during Friday’s trading session, after …

Read more